Literature DB >> 52009

Defective essential-fatty-acid metabolism in cystic fibrosis.

J P Rivers, A G Hassam.   

Abstract

Cystic fibrosis (C.F.) is characterised by low serum levels of essential fatty acids (E.F.A.). However, the fatty-acid pattern does not totally resemble that of dietary E.F.A. deficiency. The differences suggest a reduction in the desaturation of E.F.S. It is not known whether this defect is the primary lesion in C.F. or is the result of tissue damage in the disease. It is proposed that C.F. patients might have increased linoleic-acid requirements, and possibly specific requirements for its desaturation products.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52009     DOI: 10.1016/s0140-6736(75)90121-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.

Authors:  J Carlstedt-Duke; M Brönnegård; B Strandvik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  What is the association of essential fatty acid status with cystic fibrosis?

Authors:  V S Hubbard
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

3.  Fatty acid composition of serum lecithin in healthy children.

Authors:  C Alling; B Westerberg
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183

4.  Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis.

Authors:  V S Hubbard; M C McKenna
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

5.  The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells.

Authors:  J X Kang; S F Man; N E Brown; P A Labrecque; M T Clandinin
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

6.  Deficiencies of essential fatty acids and vitamin E in cystic fibrosis.

Authors:  H Böhles; H Heid; K Stehr; W Fekl
Journal:  Z Ernahrungswiss       Date:  1979-07

7.  The daily practice of pancreatic enzyme replacement therapy after pancreatic surgery: a northern European survey: enzyme replacement after surgery.

Authors:  Edmée C M Sikkens; Djuna L Cahen; Casper van Eijck; Ernst J Kuipers; Marco J Bruno
Journal:  J Gastrointest Surg       Date:  2012-06-19       Impact factor: 3.452

8.  Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation.

Authors:  Elisabetta Teopompi; Patrizia Risé; Roberta Pisi; Carola Buccellati; Marina Aiello; Giovanna Pisi; Candida Tripodi; Valentina Fainardi; Enrico Clini; Alfredo Chetta; G Enrico Rovati; Angelo Sala
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.